Birzeit Pharmaceuticals Company (PEX:BPC)
3.850
0.00 (0.00%)
At close: Apr 16, 2026
PEX:BPC Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.03 | 3.07 | 3.11 | 3 | 1.14 |
Short-Term Investments | 0.5 | 0.5 | 0.5 | - | - |
Trading Asset Securities | 3.25 | 11.93 | 13.58 | 13.63 | 12.67 |
Cash & Short-Term Investments | 4.78 | 15.5 | 17.19 | 16.63 | 13.81 |
Cash Growth | -69.17% | -9.81% | 3.38% | 20.39% | 8.82% |
Accounts Receivable | 50.11 | 40.74 | 34.53 | 37.47 | 31.74 |
Other Receivables | 2.01 | 1.35 | 2.13 | - | 1.19 |
Receivables | 52.12 | 42.08 | 36.66 | 37.47 | 32.93 |
Inventory | 12.76 | 11.84 | 13.13 | 12.2 | 11.65 |
Prepaid Expenses | 0.19 | 0.27 | 0.14 | - | 0.11 |
Other Current Assets | 0.05 | 0.37 | 0.07 | 1.92 | 1.12 |
Total Current Assets | 69.9 | 70.06 | 67.19 | 68.22 | 59.62 |
Property, Plant & Equipment | 30.42 | 29.49 | 24.31 | 22.47 | 21.13 |
Long-Term Investments | 36.64 | 27.15 | 26.97 | 25.5 | 24.07 |
Long-Term Accounts Receivable | 1.26 | 0.65 | 0.06 | 0.05 | 0.45 |
Long-Term Deferred Tax Assets | 1.72 | 1.21 | 1.27 | 1.15 | 1.1 |
Other Long-Term Assets | 0.27 | 0.27 | 5.35 | 5.61 | 5.61 |
Total Assets | 140.21 | 128.82 | 125.15 | 123 | 111.98 |
Accounts Payable | 5.77 | 3.7 | 2.03 | - | 1.59 |
Accrued Expenses | 2.09 | 2.03 | 2.18 | - | 2.31 |
Current Portion of Long-Term Debt | - | - | - | 0.42 | 0.85 |
Current Income Taxes Payable | 0.56 | - | - | - | - |
Other Current Liabilities | 4.42 | 7.11 | 3.97 | 7.15 | 2.42 |
Total Current Liabilities | 12.84 | 12.85 | 8.18 | 7.57 | 7.18 |
Long-Term Debt | - | - | - | 0.8 | 1.18 |
Pension & Post-Retirement Benefits | 12 | 11.09 | 11.94 | 11.12 | 10.83 |
Total Liabilities | 24.84 | 23.94 | 20.12 | 19.49 | 19.18 |
Common Stock | 38.76 | 38.76 | 38.76 | 38.76 | 19.38 |
Retained Earnings | 73.77 | 63.76 | 60.52 | 58.14 | 70.39 |
Treasury Stock | -0.23 | -0.23 | -0.23 | -0.23 | -0.15 |
Comprehensive Income & Other | 2.32 | 1.9 | 5.27 | 5.91 | 2.24 |
Total Common Equity | 114.63 | 104.2 | 104.32 | 102.59 | 91.86 |
Minority Interest | 0.73 | 0.68 | 0.7 | 0.92 | 0.93 |
Shareholders' Equity | 115.36 | 104.88 | 105.02 | 103.51 | 92.79 |
Total Liabilities & Equity | 140.21 | 128.82 | 125.15 | 123 | 111.98 |
Total Debt | - | - | - | 1.22 | 2.03 |
Net Cash (Debt) | 4.78 | 15.5 | 17.19 | 15.41 | 11.78 |
Net Cash Growth | -69.17% | -9.81% | 11.53% | 30.87% | 24.09% |
Net Cash Per Share | 0.12 | 0.40 | 0.44 | 0.41 | 0.30 |
Filing Date Shares Outstanding | 38.71 | 38.76 | 38.71 | 35.24 | 38.76 |
Total Common Shares Outstanding | 38.71 | 38.76 | 38.71 | 35.24 | 38.76 |
Working Capital | 57.06 | 57.21 | 59.01 | 60.65 | 52.44 |
Book Value Per Share | 2.96 | 2.69 | 2.69 | 2.91 | 2.37 |
Tangible Book Value | 114.63 | 104.2 | 104.32 | 102.59 | 91.86 |
Tangible Book Value Per Share | 2.96 | 2.69 | 2.69 | 2.91 | 2.37 |
Land | 9.39 | 9.03 | 3.95 | - | 3.58 |
Buildings | 13.38 | 11.71 | 11.71 | - | 12.24 |
Machinery | 42.62 | 41.48 | 41.19 | - | 40.56 |
Construction In Progress | 6.41 | 7.26 | 6.04 | - | 0.44 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.